Navigation Links
University Hospitals Chief Executive Officer Extends Contract
Date:12/20/2007

Thomas F. Zenty III to continue to lead UH's Historic Vision 2010 Strategic

Plan

CLEVELAND, Dec. 20 /PRNewswire/ -- University Hospitals Board of Directors has announced that Thomas F. Zenty III, Chief Executive Officer, University Hospitals, has agreed to serve as the health system's leader for an additional five years, through December 2012.

Monte Ahuja, Chairman of the UH Board of Directors, said, "I join my Board colleagues in underscoring our support for Tom and his community focused, dynamic and results-driven leadership of our health system. We look forward to working with him over the next five years to continue the momentum he has established for creating a healthier community in Northeast Ohio, an integral part of our vision for University Hospitals in 2010 and beyond."

Since joining University Hospitals (UH) in 2003 as the President and Chief Executive Officer of the health system, Mr. Zenty has worked closely with the Board of Directors, system leadership team, employees and community leaders to build a strong foundation for University Hospitals that will ensure the delivery of the highest quality patient-centered healthcare in Northeast Ohio and the nation.

Most notably, Mr. Zenty has led UH's bold and historic strategic plan, Vision 2010. Under his guidance, UH has made great strides toward achieving this vision. This year, UH has completed construction of the UH Twinsburg Health Center and broken ground for the UH Ahuja Medical Center in Beachwood. UH has also made significant investments to its main campus in Cleveland -- UH Case Medical Center -- including finalizing plans to build a new free-standing cancer hospital, Neonatal Intensive Care Unit, and Center for Emergency Medicine. UH continues to make significant investments in its community medical centers throughout the region.

During Mr. Zenty's tenure, UH has bolstered its commitment to the community by providing charit
'/>"/>

SOURCE University Hospitals
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. University of Iowa professor identifies new eating disorder
2. University of Wisconsin Hospitals and Clinics Complete System-Wide Conversion to Masimo SET Pulse Oximetry Technology
3. University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix
4. Tulane University to receive $14M for international HIV/AIDS program
5. University of Nevada School of Medicine Professor Confirms Accuracy Through Validation Study Using the CSI Health Station Model 6K
6. Boston University School of Medicine researcher recipient of Memory Ride Grant
7. Loma Linda University Medical Center Selects Beryl to Manage Call Center Interactions for Womens Services Programs and Departments
8. Medina General Hospital and University Hospitals Agree to Pursue Affiliation
9. J.D. Power and Associates Reports: Hackensack University Medical Center Recognized as First Hospital to Achieve Distinction for Providing an Outstanding Inpatient Experience in All Four Service Areas
10. The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers
11. George Mason University professor receives $2.6 million NIH grant to study Alzheimers disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...Late recurrence is a risk for some pediatric cance...central nervous system, according to a new study p...National Cancer Institute . , This study was und...recurrence (after 5 years and up to 20 years) for ...sker, M.D., of the Aflac Cancer Center and Blood D...
(Date:12/4/2009)...Case Western Reserve University researchers, from ...discovered two new metabolic pathways by which pro...e, known as 4-hydroxyacids, are metabolized. The p...lomics and mass isotopomer analysis. The findings ...rug of abuse gamma-hydroxybutyrate, also known as ...
(Date:12/4/2009)... Dental tourism is a phenom...for an alternative to the high price of dental wor... search for lower priced dental care, people have ...ce as a dental tourist destination. , ...ng in business for more than 6 years, Mexican Dent...
(Date:12/4/2009)...ve a response to pressure from federal regulators ... , FRIDAY, Dec. 4 (HealthDay News) -- The ma...riday presented federal regulators with plans to c...rmaceutical companies have been under pressure fro...ind a way to stop the hundreds of fatal overdoses ...
(Date:12/4/2009)...search and surveillance urged for at-risk patient ...s) -- Some childhood cancers, particularly Ewing s...he risk of late recurrence, U.S. researchers have ...2,795 five-year survivors of the most common pedia...ncer Survivor Study. , The researchers found th...
Breaking Medicine News(10 mins):Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 3Health News:Makers of Powerful Painkillers Present Safety Plans 2
...e of Fayette,County,s largest employers will expan...of an $8.4 million, 20-year investment by the comm...,000 grant each year through the,Fayette County Re...uction of a new,inpatient tower that will hold 56 ...
...ants for Families and Honors for Corporate Suppor...ies Affected, GURNEE, Ill., Nov. 5 This year you...oney for pediatric cancer research and,families of...uper hero costumes at this year,s Super Jake Found...
...Heart,Association and its Pharmaceutical Roundtabl...he Outcomes Research Centers initiative. The proje...troke research focusing on,the end results, or out...eart Association national board member David Spina...
...agni, President,and CEO of America,s Health Insura...ment congratulating President-elect Barack Obama:,...r his historic victory,last night. Now is the time... care challenges facing the nation. We,support cov...
...he American,Nurses Association (ANA) congratulates...tory, and looks forward to working with the new ad...change for nurses and the patients we,serve., Pre...wn a commitment to advancing the nursing professio...
...ward to health system reform in 2009, WASHINGTON,...lsen, M.D., AMA President:, "The American Medical...Obama on his successful bid for the presidency of ... President-elect Obama,s focus on expanding health...
Other Medicine News:Health News:State to Invest $8.4 Million in Uniontown Hospital's Expansion 2Health News:Super Jake Foundation Hosts 4th Annual 'Heroes Bash' on Nov. 8 to Benefit Pediatric Cancer Research 2Health News:Super Jake Foundation Hosts 4th Annual 'Heroes Bash' on Nov. 8 to Benefit Pediatric Cancer Research 3Health News:Four Medical Centers Awarded Funds to Improve Outcomes Research for Heart Disease and Stroke 2Health News:AMA Congratulates President-Elect Obama 2
(Date:12/4/2009)... , MORRISTOWN, N.J., Dec. 4 /PRNewswire-Fir...PI ), a leading global specialty pharmaceutical co... Laboratories, Inc.-Florida, filed an Abbreviated ... Drug Administration seeking approval to market it... a patent owned by Takeda Pharmaceutical Company L...
(Date:12/4/2009)... , BETHESDA, Md., Dec. 4 Drs....s for prostate-specific antigen (PSA) recurrence f...s of biochemical recurrence rate in a Phase III pi...or injection) or monthly leuprolide in prostate ca... Prostate cancer patients who received FIRMAGON 24...
(Date:12/4/2009)... , WILMINGTON, Del., Dec. 4 /PRNewswire-Firs...ed that the US Food and Drug Administration (FDA) ...ine fumarate) Extended Release Tablets as adjuncti... with Major Depressive Disorder (MDD). SEROQUEL XR...he FDA to treat both major depressive disorder as ...
Breaking Medicine Technology:Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Novel K anonymity algorithm safeguards access to data 61811 1Flax and yellow flowers can produce bioethanol 10835 1Flax and yellow flowers can produce bioethanol 10835 2Parents 3A Holiday Safety Tips from Massachusetts Child Injury Lawyer Thomas M Kiley 61808 1Parents 3A Holiday Safety Tips from Massachusetts Child Injury Lawyer Thomas M Kiley 61808 2Parents 3A Holiday Safety Tips from Massachusetts Child Injury Lawyer Thomas M Kiley 61808 3
...06, Demonstrated No Reproductive Toxicity in ... Selected as Clinical Candidate, Demonstrated a 40...ce Daily Oral Dosing -, SAN DIEGO, May 22 Ardea ... preclinical data on its lead non-nucleoside,rever...806, demonstrating,no reproductive toxicity. In ad...
...ull Data Set from the TRIUMPH-1 Trial of Inhaled ...SPRING, Md., May 21 United,Therapeutics Corporati...y,Lung Rx, Inc. today announced that data from sev...nary arterial hypertension (PAH) with treprostinil...TS) meeting in Toronto,Ontario. The ATS presentati...
Other Medicine Technology:Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program 2Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program 3Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program 4Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 2Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 3Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 4Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 5Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 6
...loped over Guidants 20-year history, the VOYAGER R...for successful treatment outcomes. It combines a n...ofile shaft,more flexible markers, and short taper...tortuous anatomy with even greater confidence, ope...
...loped over Guidants 20-year history, the VOYAGER R...for successful treatment outcomes. It combines a n...ofile shaft,more flexible markers, and short taper...tortuous anatomy with even greater confidence, ope...
...loped over Guidants 20-year history, the VOYAGER R...for successful treatment outcomes. It combines a n...ofile shaft,more flexible markers, and short taper...tortuous anatomy with even greater confidence, ope...
AFP EIA Kit
Medicine Products: